NEW MOLECULAR ENTITIES APPROVED IN 1996: Naropin
Executive Summary
1See related information
You may also be interested in...
Remote Site Visits Will Help US FDA Keep Reviews On Track As Pandemic Constraints Continue
Guidance discusses what are generically called virtual inspections, but which the agency terms “remote interactive evaluations.” As site inspections remain constrained by the pandemic, remote interactive evaluations “should help FDA operate within normal timeframes,” the document says.
Execs On The Move: Repro-Med Replaces Its CEO
At Repro-Med, James Beck has been replaced by Linda Tharby as CEO, and more.
Start-Up Spotlight: Pre Diagnostics Picks Up Momentum In Early Neurodegenerative Disease Detection
Norway’s Pre Diagnostics uses the intracellular approach to neurodegenerative disease diagnosis. It believes its technology will open up a world of precision medicine for Alzheimer’s disease patients.